NCT03189030View on ClinicalTrials.gov

Study of Personalized Immunotherapy in Adults With Metastatic Colorectal Cancer

PHASE1TerminatedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 2, 2017

Primary Completion Date

October 15, 2019

Study Completion Date

September 2, 2020

Conditions
Colorectal Neoplasms
Interventions
BIOLOGICAL

pLADD

via IV infusion

Trial Locations (5)

75230

Mary Crowley Cancer Research - Medical City, Dallas

90095

University of California Los Angeles, Los Angeles

91010

City of Hope National Medical Center, Duarte

94305

Stanford, Stanford

95817

University of California Davis Comprehensive Cancer Center, Sacramento

Sponsors
All Listed Sponsors
collaborator

Hanlee P. Ji, MD

UNKNOWN

lead

Aduro Biotech, Inc.

INDUSTRY

NCT03189030 - Study of Personalized Immunotherapy in Adults With Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter